Infinium Pharmachem Ltd

NSE : INFINIUM21 Jan 2025

Pharmaceuticals

₹

-3.50 (-1.14%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Infinium Pharmachem Ltd

Infinium Pharmachem Ltd

Pharmaceuticals

NSE : INFINIUM21 Jan 2025

₹

-3.50 (-1.14%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
07-Sep-2023	B	1:1 Bonus Issue of Equity Shares	13-Sep-2023	1:1
06-Nov-2024	BC	To consider and approve the financial results for the period ended September 30, 2024 and other business matters Infinium Pharmachem Limited has informed the Exchange regarding Board meeting held	14-Nov-2024
01-Oct-2024	BC	Infinium Pharmachem Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 23, 2024 Infinium Pharmachem Limited has informed the Exchange regardi	23-Oct-2024
26-Sep-2024	BC	Board Meeting to Consider and approve the issue of equity shares by way of preferential issue in accordance with rules and regulations of the Securities and Exchange Board of India (Issue of Capital	01-Oct-2024
02-Sep-2024	BC	20th Annual General Meeting of the company will be held on 28th September, 2024 at 11:00 a.m. at the registered office of the company. Infinium Pharmachem Limited has informed the Exchange regardi	28-Sep-2024
20-Sep-2024	BC	Annual General Meeting	23-Sep-2024

No Rights has been declared by INFINIUM

Book Closure

Record Date	Split Date	Purpose
14-Nov-2024	-	To consider and approve the financial results for the period ended September 30, 2024 and other business matters Infinium Pharmachem Limited has informed the Exchange regarding Board meeting held
23-Oct-2024	-	Infinium Pharmachem Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 23, 2024 Infinium Pharmachem Limited has informed the Exchange regardi
01-Oct-2024	-	Board Meeting to Consider and approve the issue of equity shares by way of preferential issue in accordance with rules and regulations of the Securities and Exchange Board of India (Issue of Capital
28-Sep-2024	-	20th Annual General Meeting of the company will be held on 28th September, 2024 at 11:00 a.m. at the registered office of the company. Infinium Pharmachem Limited has informed the Exchange regardi
23-Sep-2024	-	Annual General Meeting

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Infinium Pharmachem Ltd ₹304.00(-3.50/-1.14%)	304.00	-3.50	427.92	29.45	38.58	7.41
Lupin Ltd ₹2,106.75(-23.90/-1.12%)	2,106.75	-23.90	97,207.61	51.01	32.45	4.43
Ipca Laboratories Ltd ₹1,547.70(+0.60/0.04%)	1,547.70	+0.60	39,250.58	43.56	56.25	5.82
J B Chemicals & Pharmaceuticals Ltd ₹1,809.70(+7.25/0.40%)	1,809.70	+7.25	28,036.88	11.53	46.63	8.86
IOL Chemicals & Pharmaceuticals Ltd ₹399.50(-2.25/-0.56%)	399.50	-2.25	2,358.49	-10.97	23.55	1.42
Sanofi India Ltd ₹5,466.65(+63.90/1.18%)	5,466.65	+63.90	12,442.53	-35.55	29.50	18.16

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	3.32	1.54	1.24	0.14	0.12
Net Cash from Operating Activities	-15.03	7.35	9.14	6.82	2.32
Net Cash Used In Investing Activities	-3.29	-2.58	-7.17	-4.59	-1.08
Net Cash Used In Financing Activities	23.19	-3.00	-1.66	-1.12	-1.23
Net Inc./Dec In Cash And Cash Equivalents	4.86	1.77	0.31	1.10	0.02
Cash And Cash Equivalents At End Of The Year	8.18	3.32	1.54	1.24	0.14

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

65.24%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

34.76%

**Promoter pledged shareholding 65.24%

About Infinium Pharmachem Ltd

Infinium Pharmachem Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 427.92 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes Sanjaykumar Viththalbhai Patel, Sanjaykumar Viththalbhai Patel,Pravin Bhadabhai Madhani,Mitesh Lavjibhai Chikhaliya,Keyur Shah,Tarun Ratilal Dobariya,Vaishakhi Ambrishbhai Shukla (Infinium Pharmachem Ltd) among others.

Chairman

Sanjaykumar Viththalbhai Patel

Registered office

38 GIDC Sojitra,Taluka-Sojitra,Anand,Gujarat,387240

FAX :

Background

Incorporation Year2003

Face Value₹10

Market Lot1000